CommentContinuous surveillance of invasive pneumococcal disease is key
References (12)
- et al.
Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada
Vaccine
(2015) - et al.
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study
Lancet Respir Med
(2014) - et al.
Effectiveness of 10-valent pneumococcal conjugate vaccine estimated with three parallel study designs among vaccine-eligible children in Finland
Vaccine
(2020) - et al.
Twelve years of pneumococcal conjugate vaccination in the Netherlands: Impact on incidence and clinical outcomes of invasive pneumococcal disease
Vaccine
(2019) - et al.
Dynamic changes in paediatric invasive pneumococcal disease after sequential switches of conjugate vaccine in Belgium: a national retrospective observational study
Lancet Infect Dis
(2020) - et al.
Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites
PLoS Med
(2013)
There are more references available in the full text version of this article.
Cited by (0)
© 2020 Elsevier Ltd. All rights reserved.